BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2871809)

  • 1. Somatostatin mediation of adenohypophysial secretion.
    Patel YC; Srikant CB
    Annu Rev Physiol; 1986; 48():551-67. PubMed ID: 2871809
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroendocrine control of thyrotropin secretion.
    Morley JE
    Endocr Rev; 1981; 2(4):396-436. PubMed ID: 6118265
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypothalamic peptides and pituitary hormone secretion].
    Kato Y
    Horumon To Rinsho; 1979 Jan; 27(1):29-36. PubMed ID: 106992
    [No Abstract]   [Full Text] [Related]  

  • 4. In GH3 pituitary cells, acetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion.
    Onali P; Eva C; Olianas MC; Schwartz JP; Costa E
    Mol Pharmacol; 1983 Sep; 24(2):189-94. PubMed ID: 6310360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect of TRH on adenylate cyclase and cAMP in rat anterior pituitary and on TSH and PRL release into incubation medium.
    Brozmanová H; Langer P; Földes O; Kolena J; Knopp J
    Endocrinol Exp; 1980 Dec; 14(4):291-6. PubMed ID: 6257479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone (DHEA) modulates GHRH, somatostatin and angiotensin II action at the pituitary level.
    Suárez C; Vela J; García-Tornadú I; Becu-Villalobos D
    J Endocrinol; 2005 Apr; 185(1):165-72. PubMed ID: 15817837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological activity and function of growth hormone releasing factor].
    Chihara K; Kita T; Kashio Y; Okimura Y; Sato M; Fujita T
    Nihon Rinsho; 1986 Mar; 44(3):522-31. PubMed ID: 2874245
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone.
    Nicosia S; Oliva D; Giannattasio G; Spada A
    J Endocrinol Invest; 1983 Jun; 6(3):235-42. PubMed ID: 6311891
    [No Abstract]   [Full Text] [Related]  

  • 9. Melatonin reduces the production and secretion of prolactin and growth hormone from rat pituitary cells in culture.
    Griffiths D; Bjøro T; Gautvik K; Haug E
    Acta Physiol Scand; 1987 Sep; 131(1):43-9. PubMed ID: 2823532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium modifies the effects of thyroliberin and somatostatin on hormone release from cell cultures of the rat anterior pituitary.
    Komolov IS; Fedotov VP; Gudoshnikov VI; Fazekas I; Rappay G
    Endokrinologie; 1982 Nov; 80(3):318-24. PubMed ID: 6131817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyrotropin-releasing factor (author's transl)].
    Adler G
    Postepy Biochem; 1977; 23(1):3-20. PubMed ID: 404635
    [No Abstract]   [Full Text] [Related]  

  • 12. [Calcium and somatostatin interaction in regulating prolactin and somatotropic hormone release from rat adenohypophysis cells in primary culture].
    Gudoshnikov VI; Komolov IS; Fedotov VP
    Probl Endokrinol (Mosk); 1980; 26(6):50-3. PubMed ID: 6109280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secretory control of pituitary hormones--growth hormone and prolactin].
    Takeda S; Togane T; Inoue K; Irie M
    Nihon Rinsho; 1986 Mar; 44(3):587-92. PubMed ID: 2874246
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs.
    Bjøro T; Ostberg BC; Sand O; Torjesen PA; Penman E; Gordeladze JO; Iversen JG; Gautvik KM; Haug E
    Acta Physiol Scand; 1988 Jul; 133(3):271-82. PubMed ID: 2906508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-adenohypophysial communication in mammals.
    Yates FE; Russell SM; Maran JW
    Annu Rev Physiol; 1971; 33():393-444. PubMed ID: 4377649
    [No Abstract]   [Full Text] [Related]  

  • 16. Release of growth hormone from purified somatotrophs: use of perifusion system to elucidate interrelations among Ca++, adenosine 3',5'-monophosphate, and somatostatin.
    Kraicer J; Chow AE
    Endocrinology; 1982 Oct; 111(4):1173-80. PubMed ID: 6180887
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of somatostatin, newcomer from the hypothalamus.
    Guillemin R
    Vopr Biokhim Mozga; 1975; 10():117-21. PubMed ID: 1234665
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin system: molecular mechanisms regulating anterior pituitary hormones.
    Eigler T; Ben-Shlomo A
    J Mol Endocrinol; 2014 Aug; 53(1):R1-19. PubMed ID: 24780840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone releasing hormone.
    Gelato MC; Merriam GR
    Annu Rev Physiol; 1986; 48():569-91. PubMed ID: 3010827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.